Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jun;39(6):1179-84.
doi: 10.1007/BF02093781.

Gastrointestinal peptide hormones during postoperative ileus. Effect of octreotide

Affiliations

Gastrointestinal peptide hormones during postoperative ileus. Effect of octreotide

J J Cullen et al. Dig Dis Sci. 1994 Jun.

Abstract

The hypothesis was that postoperative ileus might be caused by a disturbed balance between the motor-stimulating hormones, motilin and substance P, and the motor-inhibitory hormone, vasoactive intestinal polypeptide, and that octreotide might prevent this disturbance and so ameliorate the ileus. In 15 conscious dogs with chronic gastrointestinal electrodes, electrical activity was recorded and blood was drawn for radioimmunoassay of motilin, substance P, and vasoactive intestinal peptide (VIP) during fasting and after a liquid meal. Ileus was then induced by celiotomy and intestinal abrasion. During and after operation, five dogs received 154 mM NaCl only, five dogs octreotide, 0.19 micrograms/kg/hr, and five octreotide, 0.83 micrograms/kg/hr. Plasma levels of motilin, substance P, and VIP were changed little by operation, but cyclical increases in plasma motilin, which occurred preoperatively during phase III of the interdigestive myoelectric complex, were completely abolished postoperatively during ileus, as was the complex itself. Octreotide ameliorated the ileus and restored the cyclic increases in motilin found in health, nor did it alter plasma substance P and VIP. In conclusion, octreotide ameliorates postoperative ileus, but it does not do so by increasing plasma motilin or substance P or decreasing plasma VIP.

PubMed Disclaimer

References

    1. Am J Dig Dis. 1978 Sep;23(9):789-95 - PubMed
    1. Am J Surg. 1991 Nov;162(5):499-507 - PubMed
    1. Arch Surg. 1977 Feb;112(2):203-9 - PubMed
    1. Am J Physiol. 1992 Apr;262(4 Pt 1):G616-20 - PubMed
    1. Am J Surg. 1993 Jan;165(1):113-9; discussion 119-20 - PubMed

Publication types

LinkOut - more resources